Parallax Volatility Advisers
SGYP

Parallax Volatility Advisers’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Parallax Volatility Advisers’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-50,000
Closed -$92K – 3796
2018
Q1 		$92K Hold
50,000
– – ﹤0.01% 1389
2017
Q4 		$112K Buy
+50,000
New +$124K ﹤0.01% 2742
2015
Q3 		– Sell
-67,300
Closed -$559K – 4689
2015
Q2 		$559K Buy
+67,300
New +$326K ﹤0.01% 1571

Other funds holding SGYP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Parallax Volatility Advisers's SGYP Position: Q3 2018 in Review

Parallax Volatility Advisers sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2018, closing a stake of 700 shares — an estimated $1K sold.

Parallax Volatility Advisers first reported a position in SGYP in Q3 2015 and held it in 12 quarters. The position peaked at $153K in Q4 2017. 134 funds tracked by Wall St. Rank hold SGYP as of Q3 2018.

  • Parallax Volatility Advisers reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 700 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2018, an estimated $1K.
  • Parallax Volatility Advisers first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2015 and held it in 12 quarters.
  • Parallax Volatility Advisers's Synergy Pharmaceuticals, Inc Common Stock position peaked at $153K in Q4 2017.
  • 134 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2018.

Based on Parallax Volatility Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.